Your browser doesn't support javascript.
loading
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.
Badar, Talha; Handisides, Damian R; Benito, Juliana M; Richie, Mary Ann; Borthakur, Gautam; Jabbour, Elias; Harutyunyan, Karine; Konoplev, Sergej; Faderl, Stefan; Kroll, Stew; Andreeff, Michael; Pearce, Tillman; Kantarjian, Hagop M; Cortes, Jorge E; Thomas, Deborah A; Konopleva, Marina.
Afiliación
  • Badar T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Handisides DR; Threshold Pharmaceuticals, South San Francisco, California.
  • Benito JM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Richie MA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Harutyunyan K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Konoplev S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Faderl S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kroll S; Threshold Pharmaceuticals, South San Francisco, California.
  • Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pearce T; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kantarjian HM; Threshold Pharmaceuticals, South San Francisco, California.
  • Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thomas DA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Am J Hematol ; 91(8): 800-5, 2016 08.
Article en En | MEDLINE | ID: mdl-27169385
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mostazas de Fosforamida / Leucemia / Hipoxia / Nitroimidazoles Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mostazas de Fosforamida / Leucemia / Hipoxia / Nitroimidazoles Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2016 Tipo del documento: Article